This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Case Study – Unidose Nasal Spray Pump for Epilepsy
Case Studies, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions
Building Digital Solutions To Meet The Unique Therapeutic Needs of Patients
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions
Drug Repositioning – Benefits and Challenges for Lifecycle Management
Webinars, Pharmaceutical, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions
Step to Success in Nose-to-Brain Drug Delivery
Publications, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions
